NCT02126904View on ClinicalTrials.gov

Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept

UnknownOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2013

Conditions

The Injection Burden

Interventions

DRUG

IVA group

Trial Locations (1)

232-0024

RECRUITING

Yokohama City University Medical Center, Yokohama

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Yokohama City University Medical Center

OTHER